PillSense Use in Anemia and Hemoccult
NCT: NCT06951490 · ENROLLING_BY_INVITATION
Brief Summary
In this study, participants will be offered a PillSense™ capsule, a small capsule to swallow, which can detect the presence of blood in the upper digestive tract within about 10 minutes. The results of this capsule test will not alter the current care plan but will help us assess whether PillSense™ can be used in the future as a standalone test to determine if it is safe for patients to be discharged with anemia or a positive stool test without other signs of gastrointestinal bleeding. This study aims to collect data that will help determine if the PillSense™ capsule could one day reduce the need for more invasive procedures while hospitalized, like endoscopy, and ensure safe patient discharge.
Frequently Asked Questions
What is PillSense Use in Anemia and Hemoccult?
PillSense Use in Anemia and Hemoccult is a clinical trial registered under NCT06951490. Current status: ENROLLING_BY_INVITATION.
What is the status of NCT06951490?
The current status of NCT06951490 (PillSense Use in Anemia and Hemoccult) is: ENROLLING_BY_INVITATION.
When did PillSense Use in Anemia and Hemoccult start?
PillSense Use in Anemia and Hemoccult started on 2025-05-15.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.